Table 2.
Correlations of patient clinicopathologic characteristics with exosomal miR-21 expression levels.
| Characteristics | n | miR-21 expression | P value1 | |
|---|---|---|---|---|
| Low n (%) |
High n (%) |
|||
| Age (years) | ||||
| <60 | 11 | 7 (63.6) | 4 (36.4) | 1.000 |
| ≥60 | 19 | 11 (57.9) | 8 (42.1) | |
| Gender | ||||
| Male | 23 | 13 (56.5) | 10 (43.5) | 0.669 |
| Female | 7 | 5 (71.4) | 2 (28.6) | |
| HBsAg | ||||
| Positive | 24 | 13 (54.2) | 11 (45.8) | 0.358 |
| Negative | 6 | 5 (83.3) | 1 (16.7) | |
| Liver cirrhosis | ||||
| Presence | 23 | 11 (47.8) | 12 (52.2) | 0.024 |
| Absence | 7 | 7 (100.0) | 0 (0.0) | |
| Tumor stage | ||||
| I | 10 | 9 (90.0) | 1 (10.0) | 0.001 |
| II | 7 | 5 (71.4) | 2 (28.6) | |
| III-IV | 13 | 4 (30.8) | 9 (69.2) | |
1 P < 0.05.